For: | Yeh H, Kuo CJ, Wu RC, Chen CM, Tsai WS, Su MY, Chiu CT, Le PH. Vedolizumab in Crohn’s disease with rectal fistulas and presacral abscess: A case report. World J Gastroenterol 2021; 27(5): 442-448 [PMID: 33584075 DOI: 10.3748/wjg.v27.i5.442] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i5/442.htm |
Number | Citing Articles |
1 |
Keyu Ren, Chunming Yong, Yanting Wang, Hongyun Wei, Kun Zhao, Baoguo He, Mingjuan Cui, Yunqing Chen, Jin Wang. Cytomegalovirus Pneumonia in Inflammatory Bowel Disease: Literature Review and Clinical Recommendations. Infection and Drug Resistance 2023; : 6195 doi: 10.2147/IDR.S420244
|
2 |
Yusuke Oki, Sho Nagano, Yoichi Ishikawa, Takayoshi Yamada, Toshiki Ichimori, Kazushige Uchida. Ulcerative colitis successfully treated with vedolizumab in the presence of comorbid opportunistic infections: a case report. Journal of Medical Case Reports 2023; 17(1) doi: 10.1186/s13256-023-03940-y
|
3 |
Yang Zheng, Yang Yu, Xu-Feng Chen, Sheng-Lan Yang, Xiao-Long Tang, Zheng-Guo Xiang. Intestinal Macrophage Autophagy and its Pharmacological Application in Inflammatory Bowel Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.803686
|
4 |
Chia-Jung Kuo, Puo-Hsien Le, Wei-Chen Tai, Keng-Liang Wu, Hsu-Heng Yen, Chih-Wei Yen, Shui-Yi Tung, Chen-Shuan Chung, Ming-Yao Su, Cheng-Tang Chiu. The effectiveness and safety of vedolizumab induction for moderate to severe ulcerative colitis for Asia patient: A real practice observational study. Journal of the Formosan Medical Association 2022; 121(9): 1689 doi: 10.1016/j.jfma.2021.11.012
|